How effective is Acemini? What's the price?

Asciminib (scemblix/asciminib) is a kinase inhibitor used to treat adult patients with the following:Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in the chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs) and T315Imutated chronic myelogenous leukemia Ph+chronic myelogenous leukemia.

The benefits of aximini were evaluated in a major study that included 233 adults with chronic phase Ph+ CML who had been previously treated with two or more tyrosine kinase inhibitors. In this study, aximinib was more effective than bosutinib (another tyrosine kinase inhibitor):After 24weeks of treatment, 25%AximiniThe number of cells treated with Aceminib decreased by 25%)BCR::ABL1The gene has dropped below the standard baseline1000 times), compared with 13% of patients who received bosutinib (10 out of 76 patients). After 96 weeks of treatment, 38% (59 of 157 cases) received Major molecular responses occurred in 16%of 76 patients and 12 of 76 patients who received bosutinib.

Aceminidhas been shown to reduce cell numbers more effectively than another tyrosine kinase inhibitor. BCR::ABL1Genes in patients who have been treated with at least two tyrosine kinase inhibitors. In terms of safety, the side effects of Asiminil are similar to those of this class of drugs and are considered controllable. Aximini has not yet been launched in China, but there is a version officially launched in Laos. The retail price of Lucius Pharmaceuticals in Laos40mg60tablets4 is more than a thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0